Crystalline forms of a pyridine derivative

Details for Australian Patent Application No. 2009279135 (hide)

Owner GlaxoSmithKline LLC

Inventors Anderton, Claire Louise; Clapham, David; Lawrence, Ronnie Maxwell

Agent Davies Collison Cave

Pub. Number AU-B-2009279135

PCT Pub. Number WO2010/015626

Priority 0814340.6 05.08.08 GB

Filing date 4 August 2009

Wipo publication date 11 February 2010

Acceptance publication date 13 September 2012

International Classifications

C07D 498/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/015626 Priority application(s): WO2010/015626

13 September 2012 Application Accepted

  Published as AU-B-2009279135

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009279137-Pyrazolo (5,1-b) oxazole derivatives as CRF1 antagonists

2009279123-Organic compounds